BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1898678)

  • 21. Prediction of thrombolytic therapy after stroke-bypass transportation: the Maria Prehospital Stroke Scale score.
    Hasegawa Y; Sasaki N; Yamada K; Ono H; Kumai J; Tsumura K; Suzuki K; Nozaki H; Nakayama H; Takumi I; Nikaido H; Katabami T; Ueda T; Suzuki S; Iwai R; Takahashi H; Shigeno T
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):514-9. PubMed ID: 23489953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective observational case-control study comparing prehospital thrombolytic therapy for ST-elevation myocardial infarction with in-hospital thrombolytic therapy for patients from same area.
    Chittari MS; Ahmad I; Chambers B; Knight F; Scriven A; Pitcher D
    Emerg Med J; 2005 Aug; 22(8):582-5. PubMed ID: 16046765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project.
    Kereiakes DJ; Weaver WD; Anderson JL; Feldman T; Gibler B; Aufderheide T; Williams DO; Martin LH; Anderson LC; Martin JS
    Am Heart J; 1990 Oct; 120(4):773-80. PubMed ID: 2220531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of prehospital thrombolysis in Sweden: components of delay until delivery of treatment and examination of treatment feasibility.
    Svensson L; Karlsson T; Nordlander R; Wahlin M; Zedigh C; Herlitz J
    Int J Cardiol; 2003 Apr; 88(2-3):247-56. PubMed ID: 12714205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot study of paramedic-administered, prehospital thrombolysis for acute myocardial infarction.
    Sherrid M; Greenberg H; Marsella R; Mathisen D; Lynn S; Dwyer E
    Clin Cardiol; 1990 Jun; 13(6):421-4. PubMed ID: 2344703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prehospital thrombolysis in suspected acute myocardial infarction: results from the TEAHAT Study.
    Risenfors M; Gustavsson G; Ekström L; Hartford M; Herlitz J; Karlson BW; Luepker R; Swedberg K; Wennerblom B; Holmberg S
    J Intern Med Suppl; 1991; 734():3-10. PubMed ID: 1900010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ER TIMI-19: testing the reality of prehospital thrombolysis.
    Cannon CP; Sayah AJ; Walls RM
    J Emerg Med; 2000 Oct; 19(3 Suppl):21S-25S. PubMed ID: 11050380
    [No Abstract]   [Full Text] [Related]  

  • 28. Prehospital thrombolysis perfomed by a ship's nurse with on-line physician consultation.
    Väisänen O; Mäkijärvi M; Silfvast T
    Resuscitation; 2005 Feb; 64(2):233-6. PubMed ID: 15680535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prehospital administration of thrombolytic therapy: current status in Rhode Island--results of the Prehospital Administration of t-PA Study (PATS).
    McKendall GR; Woolard RH; Williams DO
    R I Med J (1976); 1991 Sep; 74(9):405-8. PubMed ID: 1947661
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of EMS transportation on time to diagnosis and treatment of acute myocardial infarction in the emergency department.
    Swor R; Anderson W; Jackson R; Wilson A
    Prehosp Disaster Med; 1994; 9(3):160-4. PubMed ID: 10155522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prehospital thrombolytic therapy in acute myocardial infarction].
    Carlsson J; Schuster HP; Tebbe U
    Anaesthesist; 1997 Oct; 46(10):829-39. PubMed ID: 9424965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telemedicine used for remote prehospital diagnosing in patients suspected of acute myocardial infarction.
    Terkelsen CJ; Nørgaard BL; Lassen JF; Gerdes JC; Ankersen JP; Rømer F; Nielsen TT; Andersen HR
    J Intern Med; 2002 Nov; 252(5):412-20. PubMed ID: 12528759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial.
    Steg PG; Bonnefoy E; Chabaud S; Lapostolle F; Dubien PY; Cristofini P; Leizorovicz A; Touboul P;
    Circulation; 2003 Dec; 108(23):2851-6. PubMed ID: 14623806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What are the beliefs and attitudes of paramedics to prehospital thrombolysis? A questionnaire study.
    Humphrey J; Walker A; Hassan TB
    Emerg Med J; 2005 Jun; 22(6):450-1. PubMed ID: 15911960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Western Washington Myocardial Infarction Registry and Emergency Department Tissue Plasminogen Activator Treatment Trial.
    Althouse R; Maynard C; Cerqueira MD; Olsufka M; Ritchie JL; Kennedy JW
    Am J Cardiol; 1990 Dec; 66(19):1298-303. PubMed ID: 2123073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Prehospital Intervention on Delay Time to Thrombolytic Therapy in a Stroke Center with a Systemized Stroke Code Program.
    Kim DH; Nah HW; Park HS; Choi JH; Kang MJ; Huh JT; Cha JK
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1665-1670. PubMed ID: 27067887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of thrombolytic therapies with mutant tPA (lanoteplase/SUN9216) and recombinant tPA (alteplase) for acute myocardial infarction.
    Ogata N; Ogawa H; Ogata Y; Numata Y; Morigami Y; Suefuji H; Soejima H; Sakamoto T; Yasue H
    Jpn Circ J; 1998 Nov; 62(11):801-6. PubMed ID: 9856594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Thrombolysis in acute myocardial infarction. Streptokinase or r-TPA?].
    Silva LA; Ribeiro E; Carneiro RC; Kaissar S; Reis Filho A; Torossian SP; Tavares JR; Buffolo E; Amino JG; Duprat Filho R
    Arq Bras Cardiol; 1990 Jul; 55(1):13-7. PubMed ID: 2127353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intravenous thrombolysis with tissue plasminogen activator (rt-PA) at the prehospital phase of acute myocardial infarction. Apropos of 49 cases].
    Cazaux P; Leclercq G; Vahanian A; Michel PL; Soulas JM; Barriot P; Sauval P; Cupa M; Lapandry C; Conard J
    Arch Mal Coeur Vaiss; 1989 Dec; 82(12):1967-71. PubMed ID: 2515823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators.
    Van de Werf F; Cannon CP; Luyten A; Houbracken K; McCabe CH; Berioli S; Bluhmki E; Sarelin H; Wang-Clow F; Fox NL; Braunwald E
    Am Heart J; 1999 May; 137(5):786-91. PubMed ID: 10220625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.